Samuel D Colella
CIK 1201580 · Auf SEC EDGAR ansehen ↗
Erste SEC-Einreichung: 29. Oktober 2013 · Neueste: 29. Oktober 2013
Auf dieser Seite
- Insider bei Unternehmen, bei denen diese Person ein meldepflichtiger Insider ist.
- Insider-Transaktionen Jede Aktie, die diese Person gekauft oder verkauft hat, aus Formular 4-Einreichungen.
- Derivate Options- und andere Derivatebestände, die von dieser Person gemeldet werden.
- Anfängliche Bestände Die Beteiligungen, die diese Person hielt, als sie mit der Berichterstattung begann.
Insider bei
Insider-Transaktionen
Preisänderung im Vergleich zum aktuellen Kurs, bereinigt um Aktiensplits und Unternehmensmaßnahmen seit der Einreichung – nicht benchmarkt, nicht annualisiert, nicht größen-gewichtet
| Date | Ticker | Code | Aktien | Kurs | Wert | Besessen danach | Δ Eigenbesitz | A/D | vs jetzt |
|---|---|---|---|---|---|---|---|---|---|
| 11. März 2020 | LAB | P | 10.000 | $2,65 | $26.500 | 161.109 Direkt | +6,62% | Erworben | -74,5% (Preis per 2026-08-20) |
| 10. März 2020 | LAB | P | 10.000 | $2,77 | $27.700 | 151.109 Direkt | +7,09% | Erworben | -75,6% (Preis per 2026-08-20) |
| 27. August 2019 | LAB | P | 2.000 | $5,19 | $10.380 | 119.481 Direkt | +1,70% | Erworben | -87,0% (Preis per 2026-08-20) |
| 8. August 2019 | LAB | P | 1.000 | $6,65 | $6.650 | 117.481 Direkt | +0,86% | Erworben | -89,8% (Preis per 2026-08-20) |
| 7. August 2019 | LAB | P | 1.000 | $6,86 | $6.860 | 116.481 Direkt | +0,87% | Erworben | -90,1% (Preis per 2026-08-20) |
| 6. August 2019 | LAB | P | 8.000 | $7,02 | $56.160 | 115.481 Direkt | +7,44% | Erworben | -90,4% (Preis per 2026-08-20) |
| 8. August 2017 | LAB | P | 35.895 | $2,77 | $99.429 | 53.395 Indirekt | +205,11% | Erworben | -75,6% (Preis per 2026-08-20) |
| 9. Mai 2017 | LAB | P | 7.500 | $5,92 | $44.400 | 17.500 Indirekt | +75,00% | Erworben | -88,6% (Preis per 2026-08-20) |
| 14. Dezember 2016 | LAB | P | 5.000 | $7,39 | $36.950 | 44.123 Direkt | +12,78% | Erworben | -90,9% (Preis per 2026-08-20) |
| 30. November 2016 | LAB | P | 20.000 | $6,32 | $126.400 | 39.123 Direkt | +104,59% | Erworben | -89,3% (Preis per 2026-08-20) |
| 20. Februar 2015 | LAB | S | 5.700 | $38,92 | $221.844 | 19.673 Direkt | -22,46% | Veräußert | -98,3% (Preis per 2026-08-20) |
| 19. Februar 2015 | LAB | S | 38.840 | $38,97 | $1.513.595 | 19.673 Direkt | -66,38% | Veräußert | -98,3% (Preis per 2026-08-20) |
| 18. Februar 2015 | LAB | S | 8.800 | $38,71 | $340.648 | 19.673 Direkt | -30,91% | Veräußert | -98,3% (Preis per 2026-08-20) |
| 14. August 2013 | LAB | S | 10.655 | $19,89 | $211.928 | 34.585 Indirekt | -23,55% | Veräußert | -96,6% (Preis per 2026-08-20) |
| 14. August 2013 | LAB | S | 3.634 | $19,89 | $72.280 | 11.797 Indirekt | -23,55% | Veräußert | -96,6% (Preis per 2026-08-20) |
| 13. August 2013 | LAB | S | 6.638 | $19,95 | $132.428 | 45.240 Indirekt | -12,80% | Veräußert | -96,6% (Preis per 2026-08-20) |
| 13. August 2013 | LAB | S | 2.265 | $19,95 | $45.187 | 15.431 Indirekt | -12,80% | Veräußert | -96,6% (Preis per 2026-08-20) |
Zeige die neuesten 100 von 212 Transaktionen
K = Kauf auf offener Markt · V = Verkauf · A = Zuteilung/Auszeichnung · M = Optionsausübung · G = Geschenk · F = Steuereinbehalt
Insider-Transaktionen sind keine Empfehlung; Verkäufe werden oft aus Liquiditäts- oder steuerlichen Gründen getätigt.
Derivate-Bestände (Formular 4 Tabelle II)
Optionen, RSUs und wandelbare Wertpapiere, die in Formular 4 Tabelle II gemeldet werden.
| Date | Ticker | Wertpapier | Basiswert | Ausübungspreis | Verfall | Aktien | A/D |
|---|---|---|---|---|---|---|---|
| 20. Juni 2019 | LAB | Stock Option (Right to Buy) | Common Stock (10.600) | $5,57 | 31. Mai 2028 | 10.600 | Veräußert |
| 20. Juni 2019 | LAB | Stock Option (Right to Buy) | Common Stock (5.000) | $3,43 | 1. August 2027 | 5.000 | Veräußert |
| 20. Juni 2019 | LAB | Stock Option (Right to Buy) | Common Stock (3.000) | $5,44 | 1. August 2027 | 3.000 | Veräußert |
| 20. Juni 2019 | LAB | Stock Option (Right to Buy) | Common Stock (5.000) | $10,45 | 3. August 2026 | 5.000 | Veräußert |
| 3. Juni 2019 | LAB | Stock Option (Right to Buy) | Common Stock (6.796) | $13,41 | 3. Juni 2029 | 6.796 | Erworben |
| 31. Mai 2018 | LAB | Stock Option (Right to Buy) | Common Stock (10.600) | $5,57 | 31. Mai 2028 | 10.600 | Erworben |
| 30. Mai 2018 | LAB | Restricted Stock Units | Common Stock (3.000) | — | — | 3.000 | Veräußert |
| 30. Mai 2018 | LAB | Restricted Stock Units | Common Stock (5.000) | — | — | 5.000 | Veräußert |
| 31. Dezember 2017 | LAB | Restricted Stock Units | Common Stock (7.848) | — | — | 7.848 | Veräußert |
| 30. September 2017 | LAB | Restricted Stock Units | Common Stock (7.848) | — | — | 7.848 | Veräußert |
| 13. September 2017 | LAB | Stock Option (Right to Buy) | Common Stock (3.000) | $5,44 | 1. August 2027 | 3.000 | Erworben |
| 13. September 2017 | LAB | Restricted Stock Units | Common Stock (3.000) | — | — | 3.000 | Erworben |
| 8. August 2017 | LAB | Restricted Stock Units | Common Stock (15.696) | — | — | 15.696 | Erworben |
| 1. August 2017 | LAB | Stock Option (Right to Buy) | Common Stock (5.000) | $3,43 | 1. August 2027 | 5.000 | Erworben |
| 1. August 2017 | LAB | Restricted Stock Units | Common Stock (5.000) | — | — | 5.000 | Erworben |
| 31. Juli 2017 | LAB | Restricted Stock Units | Common Stock (5.000) | — | 31. Juli 2017 | 5.000 | Veräußert |
| 3. August 2016 | LAB | Restricted Stock Units | Common Stock (5.000) | — | — | 5.000 | Erworben |
| 3. August 2016 | LAB | Stock Option (Right to Buy) | Common Stock (5.000) | $10,45 | 3. August 2026 | 5.000 | Erworben |
| 29. Juli 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (10.000) | $20,59 | 29. Juli 2025 | 10.000 | Erworben |
| 20. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (5.700) | $4,45 | 28. Januar 2020 | 5.700 | Veräußert |
| 19. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (2.970) | $4,45 | 28. Januar 2020 | 2.970 | Veräußert |
| 19. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (8.670) | $8,37 | 6. Januar 2021 | 8.670 | Veräußert |
| 19. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (12.000) | $13,08 | 7. September 2021 | 12.000 | Veräußert |
| 19. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (12.000) | $14,00 | 16. Mai 2022 | 12.000 | Veräußert |
| 19. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (3.200) | $16,00 | 6. Juni 2023 | 3.200 | Veräußert |
| 18. Februar 2015 | LAB | Employee Stock Option (Right to Buy) | Common Stock (8.800) | $16,00 | 6. Juni 2023 | 8.800 | Veräußert |
| 21. Mai 2014 | LAB | Employee Stock Option (Right to Buy) | Common Stock (10.000) | $27,25 | 21. Mai 2024 | 10.000 | Erworben |
| 20. Mai 2014 | VCYT | Stock option (right to buy) | Common Stock (10.000) | $13,19 | 20. Mai 2024 | 10.000 | Erworben |
| 4. November 2013 | VCYT | Series A Convertible Preferred Stock | Common Stock (1.797.716) | — | — | 7.190.864 | Erworben |
| 4. November 2013 | VCYT | Series A Convertible Preferred Stock | Common Stock (10.617) | — | — | 42.469 | Erworben |
| 4. November 2013 | VCYT | Series B Convertible Preferred Stock | Common Stock (998.105) | — | — | 3.992.420 | Erworben |
| 4. November 2013 | VCYT | Series B Convertible Preferred Stock | Common Stock (5.895) | — | — | 23.580 | Erworben |
| 4. November 2013 | VCYT | Series C Convertible Preferred Stock | Common Stock (799.168) | — | — | 3.196.673 | Erworben |
| 4. November 2013 | VCYT | Series C Convertible Preferred Stock | Common Stock (4.720) | — | — | 18.880 | Erworben |
| 6. Juni 2013 | LAB | Employee Stock Option (Right to Buy) | Common Stock (12.000) | $16,00 | 6. Juni 2023 | 12.000 | Erworben |
| 16. Mai 2012 | LAB | Stock Option (Right to Buy) | Common Stock (12.000) | $14,00 | 16. Mai 2022 | 12.000 | Erworben |
| 11. Januar 2012 | JAZZ | Option (right to buy) | Common Stock (10.000) | $12,75 | 15. August 2017 | 10.000 | Veräußert |
| 11. Januar 2012 | JAZZ | Option (right to buy) | Common Stock (10.000) | $7,84 | 15. August 2018 | 10.000 | Veräußert |
| 11. Januar 2012 | JAZZ | Option (right to buy) | Common Stock (10.000) | $6,33 | 16. August 2019 | 10.000 | Veräußert |
| 11. Januar 2012 | JAZZ | Option (right to buy) | Common Stock (12.500) | $8,23 | 25. August 2020 | 12.500 | Veräußert |
| 11. Januar 2012 | JAZZ | Option (right to buy) | Common Stock (12.500) | $34,99 | 4. November 2021 | 12.500 | Veräußert |
| 4. November 2011 | JAZZ | Option (right to buy) | Common Stock (12.500) | $34,99 | 4. November 2021 | 12.500 | Erworben |
| 4. November 2011 | JAZZ | Phantom Stock | Common Stock (751) | — | — | 751 | Erworben |
| 8. September 2011 | LAB | Stock Option (Right to Buy) | Common Stock (12.000) | $13,08 | 7. September 2021 | 12.000 | Erworben |
| 10. März 2011 | JAZZ | Phantom Stock | Common Stock (956) | — | — | 956 | Erworben |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (10.425) | — | — | 10.425 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (2.092) | — | — | 2.092 | Veräußert |
| 15. Februar 2011 | LAB | Series D Preferred Stock | Common Stock (3.715) | — | — | 3.715 | Veräußert |
| 15. Februar 2011 | LAB | Series C Preferred Stock | Common Stock (13.442) | — | — | 13.442 | Veräußert |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (29.190) | — | — | 29.190 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (5.185) | — | — | 5.185 | Veräußert |
| 15. Februar 2011 | LAB | Series D Preferred Stock | Common Stock (1.769) | — | — | 1.769 | Veräußert |
| 15. Februar 2011 | LAB | Series C Preferred Stock | Common Stock (6.401) | — | — | 6.401 | Veräußert |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (7.297) | — | — | 7.297 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (2.065) | — | — | 2.065 | Veräußert |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (10.425) | — | — | 10.425 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (2.092) | — | — | 2.092 | Veräußert |
| 15. Februar 2011 | LAB | Series D Preferred Stock | Common Stock (3.715) | — | — | 3.715 | Veräußert |
| 15. Februar 2011 | LAB | Series C Preferred Stock | Common Stock (13.442) | — | — | 13.442 | Veräußert |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (29.190) | — | — | 29.190 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (5.185) | — | — | 5.185 | Veräußert |
| 15. Februar 2011 | LAB | Series D Preferred Stock | Common Stock (1.769) | — | — | 1.769 | Veräußert |
| 15. Februar 2011 | LAB | Series C Preferred Stock | Common Stock (6.401) | — | — | 6.401 | Veräußert |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (7.297) | — | — | 7.297 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (2.065) | — | — | 2.065 | Veräußert |
| 15. Februar 2011 | LAB | Series E-1 Preferred Warrant (Right to Buy) | Common Stock (8.257) | $0,02 | — | 8.257 | Veräußert |
| 15. Februar 2011 | LAB | Series E-1 Preferred Stock | Common Stock (7.596) | — | — | 7.596 | Veräußert |
| 15. Februar 2011 | LAB | Series E-1 Preferred Stock | Common Stock (544) | — | — | 148 | Veräußert |
| 15. Februar 2011 | LAB | Series E-1 Preferred Stock | Common Stock (346) | — | — | 346 | Veräußert |
| 15. Februar 2011 | LAB | Series E-1 Preferred Stock | Common Stock (164) | — | — | 164 | Veräußert |
| 15. Februar 2011 | LAB | Series D Preferred Stock | Common Stock (81.396) | — | — | 81.396 | Veräußert |
| 15. Februar 2011 | LAB | Series C Preferred Stock | Common Stock (294.457) | — | — | 294.457 | Veräußert |
| 15. Februar 2011 | LAB | Series B Preferred Stock | Common Stock (474.354) | — | — | 474.354 | Veräußert |
| 15. Februar 2011 | LAB | Series E Preferred Stock | Common Stock (103.546) | — | — | 103.546 | Veräußert |
| 15. Februar 2011 | LAB | Series D Preferred Stock | Common Stock (1.592) | — | — | 1.592 | Veräußert |
| 15. Februar 2011 | LAB | Series C Preferred Stock | Common Stock (5.760) | — | — | 5.760 | Veräußert |
| 25. August 2010 | JAZZ | Option (right to buy) | Common Stock (12.500) | $8,23 | 25. August 2020 | 12.500 | Erworben |
| 25. August 2010 | JAZZ | Phantom Stock | Common Stock (3.197) | — | — | 3.197 | Erworben |
| 17. August 2009 | JAZZ | Option (right to buy) | Common Stock (10.000) | $6,33 | 16. August 2019 | 10.000 | Erworben |
| 17. August 2009 | JAZZ | Phantom Stock | Common Stock (4.739) | — | — | 4.739 | Erworben |
| 15. August 2008 | JAZZ | Option (right to buy) | Common Stock (10.000) | $7,84 | 15. August 2018 | 10.000 | Erworben |
| 15. August 2008 | JAZZ | Option (right to buy) | Common Stock (10.000) | $7,84 | 15. August 2018 | 10.000 | Erworben |
| 21. Juli 2008 | JAZZ | Common Stock Warrant (right to buy) | Common Stock (129.613) | $7,37 | 21. Juli 2014 | 129.613 | Erworben |
| 21. Juli 2008 | JAZZ | Common Stock Warrant (right to buy) | Common Stock (2.464) | $7,37 | 21. Juli 2014 | 2.464 | Erworben |
| 21. Juli 2008 | JAZZ | Common Stock Warrant (right to buy) | Common Stock (1.132) | $7,37 | 21. Juli 2014 | 1.132 | Erworben |
| 15. August 2007 | JAZZ | Option (right to buy) | Common Stock (10.000) | $12,75 | 15. August 2017 | 10.000 | Erworben |
| 6. Juni 2007 | JAZZ | Series B Preferred Stock | Common Stock (563.249) | — | — | 563.249 | Veräußert |
| 6. Juni 2007 | JAZZ | Series A Preferred Stock | Common Stock (670.912) | — | — | 670.912 | Veräußert |
| 14. Mai 2007 | PODD | Series E Preferred Stock | Common Stock | — | — | 11.538 | Veräußert |
| 14. Mai 2007 | PODD | Series E Preferred Stock | Common Stock | — | — | 5.495 | Veräußert |
| 14. Mai 2007 | PODD | Series E Preferred Stock | Common Stock | — | — | 252.748 | Veräußert |
| 14. Mai 2007 | PODD | Series E Preferred Stock | Common Stock | — | — | 4.945 | Veräußert |
| 14. Mai 2007 | PODD | Series D Preferred Stock | Common Stock | — | — | 58.085 | Veräußert |
| 14. Mai 2007 | PODD | Series D Preferred Stock | Common Stock | — | — | 27.660 | Veräußert |
| 14. Mai 2007 | PODD | Series D Preferred Stock | Common Stock | — | — | 1.272.337 | Veräußert |
| 14. Mai 2007 | PODD | Series D Preferred Stock | Common Stock | — | — | 24.894 | Veräußert |
| 14. Mai 2007 | PODD | Series C Preferred Stock | Common Stock | — | — | 80.000 | Veräußert |
| 14. Mai 2007 | PODD | Series C Preferred Stock | Common Stock | — | — | 38.095 | Veräußert |
| 14. Mai 2007 | PODD | Series C Preferred Stock | Common Stock | — | — | 1.752.381 | Veräußert |
| 14. Mai 2007 | PODD | Series C Preferred Stock | Common Stock | — | — | 34.286 | Veräußert |
Zeige die neuesten 100 von 104 Transaktionen
Ausübungs-/Umwandlungspreis ist leer, wenn nicht zutreffend (z. B. RSUs).
Anfänglicher Besitz (Formular 3) 51 Beteiligungen
Wertpapiere, die beim erstmaligen Eintritt als Insider gehalten wurden, gemäß SEC Formular 3.
| Date | Ticker | Wertpapier | Aktien | Besitz |
|---|---|---|---|---|
| 29. Oktober 2013 | VCYT | Series A Convertible Preferred Stock→ Common Stock (1.797.716) | 1.797.716 | Indirekt |
| 29. Oktober 2013 | VCYT | Series A Convertible Preferred Stock→ Common Stock (10.617) | 10.617 | Indirekt |
| 29. Oktober 2013 | VCYT | Series B Convertible Preferred Stock→ Common Stock (998.105) | 998.105 | Indirekt |
| 29. Oktober 2013 | VCYT | Series B Convertible Preferred Stock→ Common Stock (5.895) | 5.895 | Indirekt |
| 29. Oktober 2013 | VCYT | Series C Convertible Preferred Stock→ Common Stock (799.168) | 799.168 | Indirekt |
| 29. Oktober 2013 | VCYT | Series C Convertible Preferred Stock→ Common Stock (4.720) | 4.720 | Indirekt |
| 9. Februar 2011 | LAB | Series E1 Preferred Stock | 164 | Indirekt |
| 9. Februar 2011 | LAB | Series E1 Preferred Stock | 346 | Indirekt |
| 9. Februar 2011 | LAB | Series E1 Preferred Stock | 148 | Indirekt |
| 9. Februar 2011 | LAB | Series E1 Preferred Stock | 7.596 | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Warrant (Right to Buy)→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series B Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series C Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series D Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Warrant (Right to Buy)→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series B Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series C Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series D Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Warrant (Right to Buy)→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series B Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series C Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series D Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Warrant (Right to Buy)→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series E Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series B Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series C Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Series D Preferred Stock→ Common Stock | — | Indirekt |
| 9. Februar 2011 | LAB | Stock Option (Right to Buy)→ Common Stock | — | Direkt |
| 9. Februar 2011 | LAB | Stock Option (Right to Buy)→ Common Stock | — | Direkt |
| 9. Februar 2011 | LAB | Series E1 Preferred Warrant (Right to Buy)→ Common Stock | — | Indirekt |
| 31. Mai 2007 | JAZZ | Series A Preferred Stock→ Common Stock (670.912) | 670.912 | Indirekt |
| 31. Mai 2007 | JAZZ | Series B Preferred Stock→ Common Stock (563.249) | 563.249 | Indirekt |
| 14. Mai 2007 | PODD | Series B Preferred Stock→ Common Stock (36.486) | 36.486 | Indirekt |
| 14. Mai 2007 | PODD | Series B Preferred Stock→ Common Stock (1.864.865) | 1.864.865 | Indirekt |
| 14. Mai 2007 | PODD | Series B Preferred Stock→ Common Stock (40.541) | 40.541 | Indirekt |
| 14. Mai 2007 | PODD | Series B Preferred Stock→ Common Stock (85.135) | 85.135 | Indirekt |
| 14. Mai 2007 | PODD | Series C Preferred Stock→ Common Stock (34.286) | 34.286 | Indirekt |
| 14. Mai 2007 | PODD | Series C Preferred Stock→ Common Stock (1.752.381) | 1.752.381 | Indirekt |
| 14. Mai 2007 | PODD | Series C Preferred Stock→ Common Stock (38.095) | 38.095 | Indirekt |
| 14. Mai 2007 | PODD | Series C Preferred Stock→ Common Stock (80.000) | 80.000 | Indirekt |
| 14. Mai 2007 | PODD | Series D Preferred Stock→ Common Stock (24.894) | 24.894 | Indirekt |
| 14. Mai 2007 | PODD | Series D Preferred Stock→ Common Stock (1.272.337) | 1.272.337 | Indirekt |
| 14. Mai 2007 | PODD | Series D Preferred Stock→ Common Stock (27.660) | 27.660 | Indirekt |
| 14. Mai 2007 | PODD | Series D Preferred Stock→ Common Stock (58.085) | 58.085 | Indirekt |
| 14. Mai 2007 | PODD | Series E Preferred Stock→ Common Stock (4.945) | 4.945 | Indirekt |
| 14. Mai 2007 | PODD | Series E Preferred Stock→ Common Stock (252.748) | 252.748 | Indirekt |
| 14. Mai 2007 | PODD | Series E Preferred Stock→ Common Stock (5.495) | 5.495 | Indirekt |